SA’s medicine dispensing ATM wins prestigious German Global Health Award
Berlin/Johannesburg – Thursday, 18 May 2017: Last night, a German / South African healthcare innovation won the German Global Health Award by the German Healthcare Partnership (GHP), the BDI (Federation of German Industry) and BIO Germany (the association of the biotechnology industry) held at the B20 Global Health Conference in Berlin. The first prize in the category ‘Small and Medium Enterprises’ of this first-ever Global Health Award was handed to MACH4 Automatisierunstechnik GmbH by the German Minister of Economic Affairs and Energy, Brigitte Zypries for innovative solutions for developing and emerging countries.
The innovative solution named Pharmacy of the Future was the result of collaboration with multiple stakeholders: Mach4 as the only technology provider willing to customize a solution for South Africa, Right e-Pharmacy who contributed their pharmacy engineering and design expertise and GIZ (German International Cooperation) South Africa. The GAUTENG DEPARTMENT OF HEALTH understood the vision and supports the pilot. Major funders of the 3-year project are the German Government and USAID.
The innovation is a ground-breaking solution which allows patients to quickly and conveniently collect their repeat prescriptions at a Pharmacy Dispensing Unit (PDU). A PDU is an ATM-like innovation using electronic and robotic technology to dispense medication. It is being piloted in collaboration with the Gauteng Department of Health at various community shopping centres.
Dirk Beils, a founder of Mach4 and Senior Director Engineering comments, “The objective of the PDU is to improve pharmacy dispensing services and access to medicines in South Africa. This German Global Health Award recognised SMEs which develop innovations especially tailored to the needs of developing and emerging countries. We are delighted to accept the award for our work in co-developing the PDU and helping to create the Pharmacy of the Future.”
Right e-Pharmacy, as the chief implementers have enhanced the project through their cloud-based information system which hosts and manages patient data and links the patient to a remote pharmacist via an audio-video link. The patient has a virtual consultation with the pharmacist. The robot of MACH4 dispenses the medication to the PDU. The cloud’s SMS system keeps users informed about their next collection dates and sends out reminders. This promotes patient retention and AIDS the early identification and intervention for patients at risk of non-adherence. The system results in positive clinical outcomes and effective patient data management.
Adherent patients with stable chronic conditions in the South African public health system currently access their medication from clinics and hospitals. PDUs enable people on chronic medication to collect their medication at a time and place which best suits them and at times when clinics are not open. The medicine ATM provides a quick, convenient repeat prescription collection option. PDUs will primarily be used to dispense chronic medication to patients, but they can be customised and developed for specific programmes such as universal test and treat or malaria campaigns.
The PDUs have the potential to improve efficiencies and medicine access in the public sector by decreasing patient waiting time and indirectly reducing the risk of co-infection of communicable diseases related to health facility congestion. The solution can also mean an economic alternative to scaling up medicine dispensing capacity in public services in a responsible and compliant manner.
Pharmacy of the Future can help to further address some of the structural issues in the public health sector such as inadequate capacity which result in patient challenges such as long waiting times and congestion. The solution also helps to transfer patients from the main public health facilities to the PDU collection sites which are placed in communities at central, easily accessible locations such as shopping centres on main transport routes. These sites also are open for extended hours including weekends and public holidays. PDUs are excellent service points for both in-hospital pharmacy requirements, as well as out-of-hospital remote dispensing requirements.
Prof Ian Sanne, CEO of Right to Care explains the benefits: “The PDU helps to significantly reduce the costs of dispensing medicines as well as to enhance patients’ compliance by reducing waiting times and distances to get the medication. It also reduces economic losses resulting from employees’ having to take time off work to collect medicines. In addition, it optimises stock management. Most importantly it improves patient care. There is a shortage of pharmacists in this country and the PDU allows tele-pharmacy through a video link built into the PDUs to best use their time, counselling patients to increase adherence.”
Says Fanie Hendriksz, MD of RIGHT EPHARMACY, a subsidiary of Right to Care, “This award is testimony to the benefits of cooperation between South Africa, Germany and the United States. Without such collaboration and innovation, we cannot advance healthcare reform in Africa. Right-ePharmacy is the centre of excellence for its parent company, spearheading disruptive innovation and enhancing differentiated models of pharmaceutical care in South Africa. Due to the early success of the pilot, we are already engaging with the ministries of health in other African countries and with more international donor organizations to expand the rollout of this innovation.”
Photographs are available here: HTTPS://DRIVE.GOOGLE.COM/OPEN?ID=0B3WP-EXYB5CBTDHFYKLIU2PILWC
Berlin: Last night in Berlin, Daniela Rudner, Senior Technical Advisor, GIZ; Dirk Beils, MD, MACH4 Germany and Dr Shabir Banoo, Chief Technical Specialist for Pharmaceutical Programmes, Right to Care with the Global Health Award.
PDU and PDU 2: A PDU is an ATM-like innovation using electronic and robotic technology to dispense medication.
About Right to Care
RIGHT TO CARE is a non-profit organization that supports and delivers prevention, care, and treatment services for HIV and TB. Through technical assistance, Right to Care supports private sector, the Department of Health and the Department of Correctional Services. In addition, through direct service delivery, Right to Care treats patients for HIV, TB, cervical cancer, medical male circumcision and sexually transmitted infections.
About Right ePharmacy
RIGHT EPHARMACY is an innovative, strategic solution provider for the dispensing, distribution and collection of medicine. The business spearheads disruptive innovation, sources, customise and implements the latest technology and systems to address key issues for better healthcare outcomes.
About Mach4 Automatisierungstechnik GmbH
Mach4 is a leading German company for automation and logistical solutions for pharmacies. It operates branch network in 11 countries. The South African company MACH4 Pharma Systems (Pty) Ltd, represented by Mr. Klaus Oster, has been established back in 2010 and is responsible for all sales and marketing activities as well as technical aspects such as installations, repairs, maintenance and service. Mach4 offers custom built equipment (robots) to suit the requirements of their customers. Mach4 systems are geared to improve efficiency in the dispensing process.
The Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH is a federal enterprise with worldwide operations in 130 countries. On behalf of the German Government it supports in the fields of international development cooperation for sustainable development and international education. Through its work, GIZ assists people and societies in shaping their own futures and improving living conditions. The German Government supports South Africa in reaching its goals as defined in the national development plan. In Pharmacy of the Future GIZ on behalf of the German Government is supporting the Project with the following: monitoring and evaluation, establishment of the call centre, training, human resources, project coordination and appropriate equipment.
For more information please contact Turquoise PR & Marketing Communications: